GlaxoSmithKline and Pfizer to Merge Consumer Health Units
GlaxoSmithKline and Pfizer plan to merge their consumer-health divisions in a joint venture with a product portfolio that would include an array of popular pain relievers, toothpastes, cold treatments, vitamins and dietary supplements. GlaxoSmithKline, which is based on Britain, will own 68 percent of the new entity; Pfizer, which has its headquarters in New York,…